Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Supported by human-centered service

Informed by industry expertise

Inspired by a commitment to care

blog

6 Complexities in Workers’ Comp Claims – and How to Address Them

Let’s look at common complexities in workers’ comp claims – and how a combination of technology, data, and people can help address them.

rxinformer

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases.

INDUSTRY SURVEY

2025 Industry Survey Report

This seventh annual survey report highlights the top challenges and priorities of 500 industry professionals.

Jeanette Connelly, PharmD, a clinical pharmacist at Healthesystems, discusses safety and cost concerns associated with physician dispensing practices in workers' compensation.

Opioids & Pain Management

Personalize my experience

Make selections below to see articles and information related to your role and interests.

This Month's Must Read

Sleep Woes: Fatigue in the Workplace

Sleep deprivation and fatigue have far-reaching consequences in the workplace, from poor productivity to injury or death.

Dec 2024

Legislation & Policy

New York Enacts Mental Injury Presumption for All Workers

All workers will now have the right to file a claim for mental injuries, based upon extraordinary work-related stress incurred on the job.

Dec 2024

Legislation & Policy

Texas Considers Making Infertility an Occupational Illness for First Responders

A proposed bill would apply to male and female reproductive systems for firefighters and EMTs.

Dec 2024

Industry Trends

Bureau of Labor Statistics Publishes Workplace Injuries and Illness Report

Private industry employers reported 2.6 million nonfatal workplace injuries and illnesses in 2023, down 8.4% from 2022.

Dec 2024

Healthe Developments

The Most Engaging RxInformer Articles from 2024

We checked the stats and reviewed our readers’ favorite articles from RxInformer magazine to bring you a list of our most engaging content from 2024.

Dec 2024

Blog

How AI Can Amplify Pharmacists’ Clinical Superpowers

How can clinical pharmacists use artificial intelligence to improve care for injured workers?

Dec 2024

Blog

Think Globally, Act Locally: Advocating for Administrative Simplification

Collaboration between national and regionally based stakeholders is one way to work towards improving the workers’ compensation system.

Nov 2024

Medmonitor

Imuldosa Approved as Stelara^® Biosimilar

This drug has been approved for the treatment of multiple chronic inflammatory disorders.

Nov 2024

This Month's Must Read

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases.

Nov 2024

Clinical Insights

Are Migraine Drugs Driving Up Pharmacy Spend?

Recent data from CWCI and WCRI, plus clinical concerns.

Nov 2024

Legislation & Policy

Minnesota Invites the Public to Complete a PTSD Survey

As part of a legislative-mandated study on work-related PTSD, the survey could influence regulator objectives for 2025.

Nov 2024

Psychedelic Developments

Could Psychedelic Injections Help with Mental Illness While Avoiding Hallucinogenic Effects?

A recent study involving the compound DOI showed promising results in mice.

Nov 2024

Industry Trends

The Impact of Adverse Weather on Workers’ Comp Claims

A new NCCI report found that hotter and colder temperatures were associated with higher claims frequency, as much as 10% higher in some cases.

Nov 2024

Medmonitor

FDA Considers Policy Changes for GLP-1 Compounds

Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.

Oct 2024

This Month's Must Read

Expert Q&A: Cybersecurity Tactics in Workers’ Compensation

Healthes’ AVP of Information Security, Tony Brown, discusses how cyber threats affect workers’ comp organizations.

Oct 2024

Opioid Developments

New Opioid Prescribing and Abuse Data

NCCI hosted a recent webinar on opioid utilization, while Fair Health published a new Opioid Tracker tool to monitor state opioid data.

Oct 2024

Industry Trends

Dermatologicals Continue to See Increases in Utilization

WCRI reports for Delaware and Philadelphia reported increases, matching patterns seen previously in other states.

Oct 2024

Legislation & Policy

New York Allows Physical and Occupational Therapy Assistants to Treat Injured Workers

These assistants must be under the supervision of a board-authorized provider.

Oct 2024

Healthe Developments

Thought Leadership from Healthesystems

A new issue of RxInformer magazine, plus Leaders Speak posts in WorkCompWire, featuring Sandy Shtab and Silvia Sacalis.

Oct 2024

RxInformer

Sleep Woes: Fatigue in the Workplace

Sleep deprivation and fatigue have far-reaching consequences in the workplace, from poor productivity to injury or death.

Winter 2024-25

RxInformer

Expert Q&A: Cybersecurity Tactics in Workers’ Compensation

RxInformer editors sat down with Healthesystems’ AVP of Information Security and resident cybersecurity expert, Tony Brown, to discuss how cyber threats affect workers’ comp organizations.

Winter 2024-25

RxInformer

From A-to-Z: 5 Population Considerations for Gen Z

Health trends in Gen Z to consider in this growing portion of the workforce.

Winter 2024-25

RxInformer

Drug Pricing Legislation and Its Impact on Workers' Comp

Lawmakers look to regulate the U.S. drug supply chain in ways that could impact workers’ comp pharmacy management.

Winter 2024-25

RxInformer

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases

Winter 2024-25

RxInformer

High Prices, High Impact: Meet the Drugs Driving Up Claim Costs in Workers’ Comp

High-impact drugs, including topicals and compounds, represent proportionately low utilization compared to opioids or NSAIDs, but they can increase pharmacy spend exponentially on impacted claims.